374886-51-8
374886-51-8
Chemical Structure
ASP2535
- CAS No.: 374886-51-8
- Formula:C22H18N6O
- Molecular Weight:382.42
IUPAC Name: 4-(3-isopropyl-5-(6-phenylpyridin-3-yl)-4H-1,2,4-triazol-4-yl)benzo[c][1,2,5]oxadiazole
InChIKey: FQGLDGKVKDPVLO-UHFFFAOYSA-N
SMILES: CC(C1=NN=C(C2=CC=C(C3=CC=CC=C3)N=C2)N1C4=CC=CC5=NON=C54)C
Biological Activity: ASP2535 is a potent, orally bioavailable, selective, brain permeable and centrally-active glycine transporter-1 (GlyT1) inhibitor. ASP2535 can improve cognitive impairment in animal models of schizophrenia and Alzheimer's disease[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
ASP2535 | 99.44% | ASP2535 is a potent, orally bioavailable, selective, brain permeable and centrally-active glycine transporter-1 (GlyT1) inhibitor. ASP2535 can improve cognitive impairment in animal models of schizophrenia and Alzheimer's disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
ASP2535 (Standard) | ≥98% | ASP2535 (Standard) is the analytical standard of ASP2535 (HY-110176). This product is intended for research and analytical applications. ASP2535 is a potent, orally bioavailable, selective, brain permeable and centrally-active glycine transporter-1 (GlyT1) inhibitor. ASP2535 can improve cognitive impairment in animal models of schizophrenia and Alzheimer's disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
